Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thermostable Flolan in Japanese PAH Patients
NCT02705807Phase 4Completed
- Sponsor
- GSK
- Start
- May 2016
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of epoprostenol in pulmonary arterial hypertension (PAH), sponsored by GSK. Started May 2016; status: completed.
02
Drugs
epoprostenol
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT02705807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02705807.